19 results
PRE 14A
SHPH
Shuttle Pharmaceuticals Holdings Inc
10 Jun 24
Preliminary proxy
6:12am
, Gastrointestinal Marketing; and Director, Oncology and Renal Marketing and Commercial Development. He began working in the healthcare and pharmaceutical
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
side effects, and greater cost-effectiveness.
Escalating healthcare spending is adding pressure on government and commercial payors to contain drug … be approved by CMS or developed by a variety of healthcare entities to begin operating under the ACA in 2017. We expect the growth in ACOs to continue
8-K
EX-10.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
applicable law or humanitarian programs provided by a governmental agency or licensed nonprofit healthcare institution.
Provided Company, its Affiliates
424B3
l0l7pv c1wha5trio06
24 Aug 23
Prospectus supplement
2:00pm
DEF 14A
nyr 7q70tw
21 Nov 22
Definitive proxy
5:28pm
DRS
ad74b 1q8v
29 Sep 22
Draft registration statement
12:00am
424B4
yz84hz
31 Aug 22
Prospectus supplement with pricing info
6:16am
S-1
EX-10.31
jghgfe64okbmb0 3q
3 Jun 22
IPO registration
5:32pm
S-1
n4bt45qdu
3 Jun 22
IPO registration
5:32pm
DRS/A
xsd105yp3r3wzjgf8x
26 Apr 22
Draft registration statement (amended)
12:00am
DRS
u35ijth peew
16 Sep 19
Draft registration statement
12:00am
- Prev
- 1
- Next